Risks for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection

HIV Medicine

Volumn 11, Issue 6, 2010, Pages 389-394

  Ramsetty, S K ^a   Stuart, L L ^a   Blake, R T ^a   Parsons, C H ^a   Salgado, C D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

HIV; Methicillin resistant Staphylococcus aureus; USA 300

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CD4 ANTIGEN; COTRIMOXAZOLE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK REDUCTION; SKIN INFECTION; SOFT TISSUE INFECTION;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTI-RETROVIRAL AGENTS; CARRIER STATE; CD4 LYMPHOCYTE COUNT; COMORBIDITY; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NOSE; OUTPATIENTS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; VIRAL LOAD; YOUNG ADULT;

EID: 77954613857     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00802.x     Document Type: Article

References (18)

1. Senthilkumar A, Kumar S, Sheagren J. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis 2001, 33:1412-1416.
2. Nguyen MH, Kauffman CA, Goodman RP. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999, 130:221-225.
3. Gorwitz RJ, Kruszon-Moran D, McAllister SK. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008, 197:1226-1234.
4. Weinke T, Schiller R, Fehrenbach FJ. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992, 11:985-989.
5. Tumbarello M, Donati KG, Tacconelli E. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002, 50:375-382.
6. Klevens RM, Morrison MA, Nadle J. Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States. JAMA 2007, 298:1763-1771.
7. Mathews WC, Caperna JC, Barber RE. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005, 40:155-160.
8. Skiest D, Brown K, Hester J. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med 2006, 7:361-368.
9. Drapeau CM, Angeletti C, Festa A. Role of previous hospitalization in clinically significant MRSA infection among HIV-infected inpatients: results of a case-control study. BMC Infect Dis 2007, 7:36.
10. Crum-Cianflone N, Hale B, Burgi A. Increasing rates of community-acquired MRSA infections among HIV-infected persons. Toronto, 2006 [Abstract MOAB0304]
11. Onorato M, Borucki MJ, Baillargeon G. Risk factors for colonization or infection due to methicillin-resistant Staphylococcus aureus in HIV-positive patients: a retrospective case-control study. Infect Control Hosp Epidemiol 1999, 20:26-30.
12. Padoveze MC, Tresoldi AT, von Nowakonski A. Nasal MRSA colonization of AIDS patients cared for in a Brazilian university hospital. Infect Control Hosp Epidemiol 2001, 22:783-785.
13. Villacian JS, Barkham T, Earnest A. Prevalence of and risk factors for nasal colonization with Staphylococcus aureus among human immunodeficiency virus-positive outpatients in Singapore. Infect Control Hosp Epidemiol 2004, 25:438-440.
14. Gallant JE. When to start antiretroviral therapy: a swinging pendulum? Top HIV Med 2008, 16:82-88.
15. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005, 26:916-922.
16. Tacconelli E, Carmeli Y, Aizer A. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003, 37:1629-1638.
17. Diep BA, Gill SR, Chang RF. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 2006, 367:731-739.
18. Diep BA, Chambers HF, Graber CJ. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008, 148:249-257.